Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
STERIS Life Sciences
STERIS Life Sciences
Activities:
Infection Control
Trending Articles
PCI Pharma Serives acquires US-based sterile fill-finish CDMO, Ajinomoto Althea
This acquisition will add antibody-drug conjugate (ADC) manufacturing and US-based sterile fill-finish production capabilities to PCI's portfolio
Roche to put $50bn into US manufacturing and R&D footprint
The company will build new gene therapy, weight loss medication and continuous glucose monitoring manufacturing facilities situated across the US, as well as dedicated R&D centres
Thermo Fisher Scientific to invest $2bn into US manufacturing capabilities
The life science service provider will put 75% of the $2bn into its US pharmaceutical manufacturing capacities, helping to produce key medicines for the market
Jazz Pharmaceuticals commercialises enhanced antibody, Ziihera, for biliary tract cancer
The therapeutic antibody was developed using ProBioGen's GlyMaxX technology, creating an afucosylated product with more ADCC-mediated cell killing activity
Rethinking capsules: How HPMC is changing the game in OSD
29 May 2025 | Virtual
Upcoming event
Making Pharmaceuticals
29-30 April 2025 | Conference | Coventry, UK
See all
Related Content
Manufacturing
Big names announced for leading Pharma and Cleanroom conference
The Cleanroom Technology Conference and Manufacturing Chemist Live collaboration will take place on the 10-11 November. Delegate tickets are currently available
Containment
ChargePoint and STERIS collaborate on fully validated sterile transfer solution
New collaboration has integrated technologies for sterile transfer of drug substances and drug products during biopharmaceutical manufacturing
Packaging
Particulate contamination is a concern for critical product contact surfaces
Data shows that STERIS BPS materials generate a fraction of the particles generated by cellulose based products
Finance
STERIS reports 9% revenue growth
“Fiscal 2020 is shaping up to be a great year,” says CEO on the latest financial report
Manufacturing
How to reduce tableting costs without losing quality or efficiency
Stephen Natoli of Natoli Engineering Company discusses how to reduce costs while maintaining or increasing output and efficiency
Pharmaceutical
Editor’s pick: Must see at Interphex 2018
The who’s and what’s on the show floor at the International Pharmaceutical Expo in New York
Cleaning
STERIS launches Reliance 980PG Pharmaceutical Grade Washer
The washing system provides advanced cleaning assurance for automated washing needs
Subscribe now